nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ABCC2—epilepsy syndrome	0.177	0.432	CbGaD
Sulfasalazine—ABCG2—epilepsy syndrome	0.157	0.382	CbGaD
Sulfasalazine—PTGS2—epilepsy syndrome	0.0768	0.187	CbGaD
Sulfasalazine—ABCC2—Levetiracetam—epilepsy syndrome	0.0746	0.198	CbGbCtD
Sulfasalazine—ABCC2—Carbamazepine—epilepsy syndrome	0.0428	0.114	CbGbCtD
Sulfasalazine—ABCC2—Phenytoin—epilepsy syndrome	0.0384	0.102	CbGbCtD
Sulfasalazine—ABCC2—Phenobarbital—epilepsy syndrome	0.0342	0.0909	CbGbCtD
Sulfasalazine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0342	0.0907	CbGbCtD
Sulfasalazine—PTGS1—Diazepam—epilepsy syndrome	0.0271	0.0719	CbGbCtD
Sulfasalazine—CYP3A5—Carbamazepine—epilepsy syndrome	0.0215	0.057	CbGbCtD
Sulfasalazine—PTGS1—Valproic Acid—epilepsy syndrome	0.0214	0.0567	CbGbCtD
Sulfasalazine—CYP3A5—Phenytoin—epilepsy syndrome	0.0192	0.0511	CbGbCtD
Sulfasalazine—CYP3A5—Phenobarbital—epilepsy syndrome	0.0172	0.0456	CbGbCtD
Sulfasalazine—CYP3A5—Midazolam—epilepsy syndrome	0.0169	0.0449	CbGbCtD
Sulfasalazine—CYP3A5—Diazepam—epilepsy syndrome	0.0163	0.0432	CbGbCtD
Sulfasalazine—CYP3A5—Valproic Acid—epilepsy syndrome	0.0128	0.034	CbGbCtD
Sulfasalazine—TBXAS1—forelimb—epilepsy syndrome	0.00739	0.119	CbGeAlD
Sulfasalazine—SLC7A11—tongue—epilepsy syndrome	0.0029	0.0468	CbGeAlD
Sulfasalazine—PPARG—forelimb—epilepsy syndrome	0.00278	0.045	CbGeAlD
Sulfasalazine—ACAT1—forebrain—epilepsy syndrome	0.002	0.0324	CbGeAlD
Sulfasalazine—ACAT1—telencephalon—epilepsy syndrome	0.00184	0.0298	CbGeAlD
Sulfasalazine—TBXAS1—forebrain—epilepsy syndrome	0.00167	0.0271	CbGeAlD
Sulfasalazine—ACAT1—medulla oblongata—epilepsy syndrome	0.00145	0.0234	CbGeAlD
Sulfasalazine—ACAT1—midbrain—epilepsy syndrome	0.00132	0.0214	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—epilepsy syndrome	0.00129	0.0209	CbGeAlD
Sulfasalazine—SLC7A11—forebrain—epilepsy syndrome	0.00123	0.0199	CbGeAlD
Sulfasalazine—ACAT1—head—epilepsy syndrome	0.00115	0.0185	CbGeAlD
Sulfasalazine—SLC7A11—telencephalon—epilepsy syndrome	0.00113	0.0183	CbGeAlD
Sulfasalazine—ACAT1—nervous system—epilepsy syndrome	0.00109	0.0176	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—epilepsy syndrome	0.00105	0.0169	CbGeAlD
Sulfasalazine—ACAT1—cerebellum—epilepsy syndrome	0.00102	0.0165	CbGeAlD
Sulfasalazine—SLC46A1—spinal cord—epilepsy syndrome	0.000961	0.0155	CbGeAlD
Sulfasalazine—TBXAS1—head—epilepsy syndrome	0.000959	0.0155	CbGeAlD
Sulfasalazine—IKBKB—telencephalon—epilepsy syndrome	0.000933	0.0151	CbGeAlD
Sulfasalazine—TBXAS1—nervous system—epilepsy syndrome	0.000909	0.0147	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—epilepsy syndrome	0.000875	0.0141	CbGeAlD
Sulfasalazine—SLC46A1—head—epilepsy syndrome	0.000854	0.0138	CbGeAlD
Sulfasalazine—CHUK—head—epilepsy syndrome	0.000854	0.0138	CbGeAlD
Sulfasalazine—ACAT1—brain—epilepsy syndrome	0.000831	0.0134	CbGeAlD
Sulfasalazine—SLC7A11—midbrain—epilepsy syndrome	0.000811	0.0131	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—epilepsy syndrome	0.00081	0.0131	CbGeAlD
Sulfasalazine—PTGS1—ganglion—epilepsy syndrome	0.000804	0.013	CbGeAlD
Sulfasalazine—PLA2G1B—head—epilepsy syndrome	0.000803	0.013	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—epilepsy syndrome	0.000792	0.0128	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—epilepsy syndrome	0.00078	0.0126	CbGeAlD
Sulfasalazine—CHUK—cerebellum—epilepsy syndrome	0.000762	0.0123	CbGeAlD
Sulfasalazine—SLC46A1—cerebellum—epilepsy syndrome	0.000762	0.0123	CbGeAlD
Sulfasalazine—PLA2G1B—nervous system—epilepsy syndrome	0.000762	0.0123	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—epilepsy syndrome	0.000733	0.0118	CbGeAlD
Sulfasalazine—SLC7A11—head—epilepsy syndrome	0.000704	0.0114	CbGeAlD
Sulfasalazine—TBXAS1—brain—epilepsy syndrome	0.000695	0.0112	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—epilepsy syndrome	0.000667	0.0108	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—epilepsy syndrome	0.000642	0.0104	CbGeAlD
Sulfasalazine—PPARG—forebrain—epilepsy syndrome	0.000631	0.0102	CbGeAlD
Sulfasalazine—SLC7A11—cerebellum—epilepsy syndrome	0.000628	0.0101	CbGeAlD
Sulfasalazine—CHUK—brain—epilepsy syndrome	0.000619	0.01	CbGeAlD
Sulfasalazine—SLC46A1—brain—epilepsy syndrome	0.000619	0.01	CbGeAlD
Sulfasalazine—PLA2G1B—brain—epilepsy syndrome	0.000582	0.00941	CbGeAlD
Sulfasalazine—IKBKB—head—epilepsy syndrome	0.000581	0.00939	CbGeAlD
Sulfasalazine—IKBKB—nervous system—epilepsy syndrome	0.000551	0.0089	CbGeAlD
Sulfasalazine—IKBKB—central nervous system—epilepsy syndrome	0.00053	0.00857	CbGeAlD
Sulfasalazine—IKBKB—cerebellum—epilepsy syndrome	0.000518	0.00837	CbGeAlD
Sulfasalazine—SLC7A11—brain—epilepsy syndrome	0.00051	0.00824	CbGeAlD
Sulfasalazine—Vismodegib—ABCG2—epilepsy syndrome	0.0005	0.232	CrCbGaD
Sulfasalazine—ALOX5—head—epilepsy syndrome	0.000481	0.00778	CbGeAlD
Sulfasalazine—ALOX5—nervous system—epilepsy syndrome	0.000456	0.00737	CbGeAlD
Sulfasalazine—ALOX5—central nervous system—epilepsy syndrome	0.000439	0.0071	CbGeAlD
Sulfasalazine—ALOX5—cerebellum—epilepsy syndrome	0.000429	0.00694	CbGeAlD
Sulfasalazine—IKBKB—brain—epilepsy syndrome	0.000421	0.0068	CbGeAlD
Sulfasalazine—Vismodegib—CYP2C19—epilepsy syndrome	0.000393	0.183	CrCbGaD
Sulfasalazine—ABCG2—telencephalon—epilepsy syndrome	0.000372	0.00601	CbGeAlD
Sulfasalazine—PPARG—head—epilepsy syndrome	0.000361	0.00584	CbGeAlD
Sulfasalazine—ALOX5—brain—epilepsy syndrome	0.000349	0.00564	CbGeAlD
Sulfasalazine—PPARG—nervous system—epilepsy syndrome	0.000343	0.00554	CbGeAlD
Sulfasalazine—PTGS1—forebrain—epilepsy syndrome	0.000337	0.00545	CbGeAlD
Sulfasalazine—PPARG—central nervous system—epilepsy syndrome	0.00033	0.00533	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—epilepsy syndrome	0.000328	0.153	CrCbGaD
Sulfasalazine—PTGS2—forebrain—epilepsy syndrome	0.000323	0.00521	CbGeAlD
Sulfasalazine—PTGS1—telencephalon—epilepsy syndrome	0.00031	0.00501	CbGeAlD
Sulfasalazine—PTGS2—telencephalon—epilepsy syndrome	0.000297	0.00479	CbGeAlD
Sulfasalazine—ABCG2—medulla oblongata—epilepsy syndrome	0.000292	0.00472	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—epilepsy syndrome	0.000279	0.13	CrCbGaD
Sulfasalazine—ABCG2—midbrain—epilepsy syndrome	0.000267	0.00432	CbGeAlD
Sulfasalazine—PPARG—brain—epilepsy syndrome	0.000262	0.00423	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—epilepsy syndrome	0.000261	0.00421	CbGeAlD
Sulfasalazine—PTGS2—medulla oblongata—epilepsy syndrome	0.000233	0.00377	CbGeAlD
Sulfasalazine—Sulfaphenazole—CYP2D6—epilepsy syndrome	0.000225	0.105	CrCbGaD
Sulfasalazine—Vismodegib—ALB—epilepsy syndrome	0.000218	0.101	CrCbGaD
Sulfasalazine—PTGS1—spinal cord—epilepsy syndrome	0.000217	0.00351	CbGeAlD
Sulfasalazine—PTGS2—midbrain—epilepsy syndrome	0.000213	0.00344	CbGeAlD
Sulfasalazine—Vismodegib—ABCB1—epilepsy syndrome	0.000208	0.0967	CrCbGaD
Sulfasalazine—PTGS2—spinal cord—epilepsy syndrome	0.000208	0.00336	CbGeAlD
Sulfasalazine—ABCG2—cerebellum—epilepsy syndrome	0.000207	0.00334	CbGeAlD
Sulfasalazine—PTGS1—head—epilepsy syndrome	0.000193	0.00312	CbGeAlD
Sulfasalazine—PTGS2—head—epilepsy syndrome	0.000185	0.00298	CbGeAlD
Sulfasalazine—PTGS1—nervous system—epilepsy syndrome	0.000183	0.00296	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—epilepsy syndrome	0.000176	0.00285	CbGeAlD
Sulfasalazine—PTGS2—nervous system—epilepsy syndrome	0.000175	0.00283	CbGeAlD
Sulfasalazine—PTGS2—central nervous system—epilepsy syndrome	0.000169	0.00272	CbGeAlD
Sulfasalazine—ABCG2—brain—epilepsy syndrome	0.000168	0.00271	CbGeAlD
Sulfasalazine—PTGS2—cerebellum—epilepsy syndrome	0.000165	0.00266	CbGeAlD
Sulfasalazine—PTGS1—brain—epilepsy syndrome	0.00014	0.00226	CbGeAlD
Sulfasalazine—PTGS2—brain—epilepsy syndrome	0.000134	0.00216	CbGeAlD
Sulfasalazine—CHUK—Immune System—CRP—epilepsy syndrome	5.18e-06	3.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUNB—epilepsy syndrome	5.16e-06	3.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CNR1—epilepsy syndrome	5.16e-06	3.47e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	5.15e-06	3.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CCR5—epilepsy syndrome	5.14e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.14e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PLCB1—epilepsy syndrome	5.14e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TH—epilepsy syndrome	5.13e-06	3.46e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	5.12e-06	3.45e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.09e-06	3.43e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	5.08e-06	3.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR2—epilepsy syndrome	5.07e-06	3.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SST—epilepsy syndrome	5.07e-06	3.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NTRK2—epilepsy syndrome	5.07e-06	3.41e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—BCHE—epilepsy syndrome	5.06e-06	3.41e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.05e-06	3.4e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HTR7—epilepsy syndrome	5.03e-06	3.39e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—DUSP6—epilepsy syndrome	5.02e-06	3.38e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ADRA2A—epilepsy syndrome	4.96e-06	3.34e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PLAT—epilepsy syndrome	4.94e-06	3.32e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HBEGF—epilepsy syndrome	4.88e-06	3.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	4.88e-06	3.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—JUN—epilepsy syndrome	4.87e-06	3.28e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—BCHE—epilepsy syndrome	4.86e-06	3.27e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GPX1—epilepsy syndrome	4.86e-06	3.27e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—epilepsy syndrome	4.85e-06	3.27e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	4.82e-06	3.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—SRC—epilepsy syndrome	4.82e-06	3.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT3—epilepsy syndrome	4.79e-06	3.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TSC2—epilepsy syndrome	4.78e-06	3.22e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PRKCB—epilepsy syndrome	4.78e-06	3.22e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PLCB1—epilepsy syndrome	4.77e-06	3.21e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BDKRB2—epilepsy syndrome	4.76e-06	3.21e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL12—epilepsy syndrome	4.76e-06	3.21e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—epilepsy syndrome	4.76e-06	3.21e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6ST—epilepsy syndrome	4.76e-06	3.2e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TH—epilepsy syndrome	4.75e-06	3.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TSC2—epilepsy syndrome	4.69e-06	3.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CRP—epilepsy syndrome	4.69e-06	3.16e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—epilepsy syndrome	4.68e-06	3.16e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ADAM10—epilepsy syndrome	4.68e-06	3.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOE—epilepsy syndrome	4.68e-06	3.15e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CNR1—epilepsy syndrome	4.67e-06	3.15e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUNB—epilepsy syndrome	4.67e-06	3.15e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PLCB1—epilepsy syndrome	4.66e-06	3.14e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCG2—epilepsy syndrome	4.65e-06	3.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	4.63e-06	3.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—SRC—epilepsy syndrome	4.63e-06	3.12e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—epilepsy syndrome	4.62e-06	3.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PLCB1—epilepsy syndrome	4.58e-06	3.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TH—epilepsy syndrome	4.57e-06	3.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HTR7—epilepsy syndrome	4.56e-06	3.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	4.54e-06	3.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	4.51e-06	3.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.5e-06	3.03e-05	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—epilepsy syndrome	4.49e-06	3.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.48e-06	3.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HBEGF—epilepsy syndrome	4.43e-06	2.98e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—S100B—epilepsy syndrome	4.43e-06	2.98e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SLC2A1—epilepsy syndrome	4.39e-06	2.96e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6ST—epilepsy syndrome	4.39e-06	2.96e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SOCS3—epilepsy syndrome	4.38e-06	2.95e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDC42—epilepsy syndrome	4.37e-06	2.95e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	4.37e-06	2.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—SRC—epilepsy syndrome	4.37e-06	2.94e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JUNB—epilepsy syndrome	4.36e-06	2.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FOS—epilepsy syndrome	4.36e-06	2.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS2—epilepsy syndrome	4.36e-06	2.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT3—epilepsy syndrome	4.35e-06	2.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PRKCB—epilepsy syndrome	4.33e-06	2.92e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS1—epilepsy syndrome	4.33e-06	2.92e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6ST—epilepsy syndrome	4.31e-06	2.91e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.3e-06	2.89e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	4.29e-06	2.89e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	4.26e-06	2.87e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AGT—epilepsy syndrome	4.26e-06	2.87e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CASP8—epilepsy syndrome	4.26e-06	2.87e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ADAM10—epilepsy syndrome	4.24e-06	2.86e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	4.23e-06	2.85e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AVP—epilepsy syndrome	4.23e-06	2.85e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CAT—epilepsy syndrome	4.23e-06	2.85e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—SRC—epilepsy syndrome	4.2e-06	2.83e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOE—epilepsy syndrome	4.17e-06	2.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HBEGF—epilepsy syndrome	4.13e-06	2.78e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	4.11e-06	2.77e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.08e-06	2.75e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	4.07e-06	2.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT3—epilepsy syndrome	4.05e-06	2.73e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—S100B—epilepsy syndrome	4.01e-06	2.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HES1—epilepsy syndrome	4e-06	2.7e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SOCS3—epilepsy syndrome	3.97e-06	2.68e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—HMOX1—epilepsy syndrome	3.97e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDC42—epilepsy syndrome	3.97e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ADAM10—epilepsy syndrome	3.96e-06	2.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FOS—epilepsy syndrome	3.95e-06	2.66e-05	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—epilepsy syndrome	3.92e-06	2.64e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CAT—epilepsy syndrome	3.92e-06	2.64e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FYN—epilepsy syndrome	3.89e-06	2.62e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—H2AFX—epilepsy syndrome	3.88e-06	2.61e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	3.87e-06	2.61e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MEF2C—epilepsy syndrome	3.87e-06	2.61e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CASP8—epilepsy syndrome	3.86e-06	2.6e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—BCHE—epilepsy syndrome	3.86e-06	2.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FGF2—epilepsy syndrome	3.85e-06	2.59e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AVP—epilepsy syndrome	3.84e-06	2.59e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3.82e-06	2.58e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.82e-06	2.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—HMOX1—epilepsy syndrome	3.81e-06	2.57e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ABCB1—epilepsy syndrome	3.81e-06	2.56e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAT—epilepsy syndrome	3.76e-06	2.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—YWHAZ—epilepsy syndrome	3.74e-06	2.52e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NGF—epilepsy syndrome	3.7e-06	2.49e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDC42—epilepsy syndrome	3.7e-06	2.49e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	3.68e-06	2.48e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ABCB1—epilepsy syndrome	3.66e-06	2.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BCL2—epilepsy syndrome	3.65e-06	2.46e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLCB1—epilepsy syndrome	3.64e-06	2.45e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.64e-06	2.45e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HES1—epilepsy syndrome	3.63e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TH—epilepsy syndrome	3.63e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.62e-06	2.44e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—epilepsy syndrome	3.61e-06	2.43e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR5—epilepsy syndrome	3.6e-06	2.42e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—POMC—epilepsy syndrome	3.58e-06	2.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—RELA—epilepsy syndrome	3.57e-06	2.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FGF2—epilepsy syndrome	3.55e-06	2.39e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GPX1—epilepsy syndrome	3.54e-06	2.38e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FYN—epilepsy syndrome	3.53e-06	2.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HTR2A—epilepsy syndrome	3.52e-06	2.37e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—H2AFX—epilepsy syndrome	3.52e-06	2.37e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MEF2C—epilepsy syndrome	3.51e-06	2.36e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MTOR—epilepsy syndrome	3.5e-06	2.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FGF2—epilepsy syndrome	3.49e-06	2.35e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	3.46e-06	2.33e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	3.42e-06	2.3e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TH—epilepsy syndrome	3.41e-06	2.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GPX1—epilepsy syndrome	3.4e-06	2.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—YWHAZ—epilepsy syndrome	3.39e-06	2.29e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HES1—epilepsy syndrome	3.39e-06	2.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NGF—epilepsy syndrome	3.36e-06	2.26e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AGT—epilepsy syndrome	3.35e-06	2.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TSC2—epilepsy syndrome	3.35e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AGT—epilepsy syndrome	3.34e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BCL2—epilepsy syndrome	3.31e-06	2.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FYN—epilepsy syndrome	3.29e-06	2.22e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—epilepsy syndrome	3.29e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—H2AFX—epilepsy syndrome	3.28e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—epilepsy syndrome	3.28e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—epilepsy syndrome	3.27e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—epilepsy syndrome	3.27e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR5—epilepsy syndrome	3.26e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—RELA—epilepsy syndrome	3.24e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MTOR—epilepsy syndrome	3.23e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—epilepsy syndrome	3.23e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KDR—epilepsy syndrome	3.21e-06	2.16e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—epilepsy syndrome	3.2e-06	2.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HTR2A—epilepsy syndrome	3.19e-06	2.15e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MTOR—epilepsy syndrome	3.18e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—YWHAZ—epilepsy syndrome	3.17e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—JUN—epilepsy syndrome	3.13e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AGT—epilepsy syndrome	3.1e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRKCB—epilepsy syndrome	3.09e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6ST—epilepsy syndrome	3.08e-06	2.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CCR5—epilepsy syndrome	3.05e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—epilepsy syndrome	3.04e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TSC2—epilepsy syndrome	3.03e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AGT—epilepsy syndrome	3.03e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HMOX1—epilepsy syndrome	3.03e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—epilepsy syndrome	3e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—epilepsy syndrome	2.99e-06	2.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AGT—epilepsy syndrome	2.98e-06	2.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—epilepsy syndrome	2.97e-06	2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—epilepsy syndrome	2.93e-06	1.97e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—epilepsy syndrome	2.92e-06	1.97e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KDR—epilepsy syndrome	2.91e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCB1—epilepsy syndrome	2.9e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—epilepsy syndrome	2.88e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—epilepsy syndrome	2.86e-06	1.93e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.84e-06	1.91e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—epilepsy syndrome	2.84e-06	1.91e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TSC2—epilepsy syndrome	2.83e-06	1.91e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.82e-06	1.9e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—POMC—epilepsy syndrome	2.81e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—epilepsy syndrome	2.81e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.81e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRKCB—epilepsy syndrome	2.8e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6ST—epilepsy syndrome	2.79e-06	1.88e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—epilepsy syndrome	2.77e-06	1.87e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—epilepsy syndrome	2.75e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.73e-06	1.84e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—epilepsy syndrome	2.72e-06	1.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—epilepsy syndrome	2.7e-06	1.82e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—POMC—epilepsy syndrome	2.61e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—epilepsy syndrome	2.61e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6ST—epilepsy syndrome	2.6e-06	1.75e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—epilepsy syndrome	2.59e-06	1.75e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—epilepsy syndrome	2.58e-06	1.74e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.57e-06	1.73e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—POMC—epilepsy syndrome	2.55e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—epilepsy syndrome	2.55e-06	1.71e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.54e-06	1.71e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—POMC—epilepsy syndrome	2.51e-06	1.69e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—epilepsy syndrome	2.5e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGF2—epilepsy syndrome	2.49e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—epilepsy syndrome	2.38e-06	1.6e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AGT—epilepsy syndrome	2.37e-06	1.59e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—epilepsy syndrome	2.32e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—epilepsy syndrome	2.32e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RELA—epilepsy syndrome	2.31e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—epilepsy syndrome	2.29e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MTOR—epilepsy syndrome	2.26e-06	1.53e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF2—epilepsy syndrome	2.26e-06	1.52e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	2.25e-06	1.52e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.22e-06	1.5e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.18e-06	1.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF2—epilepsy syndrome	2.1e-06	1.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RELA—epilepsy syndrome	2.09e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.08e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—epilepsy syndrome	2.08e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—epilepsy syndrome	2.02e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—POMC—epilepsy syndrome	1.99e-06	1.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—epilepsy syndrome	1.97e-06	1.33e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTOR—epilepsy syndrome	1.92e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-06	1.27e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.87e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—epilepsy syndrome	1.85e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—epilepsy syndrome	1.83e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—epilepsy syndrome	1.82e-06	1.22e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—epilepsy syndrome	1.81e-06	1.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—epilepsy syndrome	1.79e-06	1.2e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—epilepsy syndrome	1.77e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—epilepsy syndrome	1.74e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.71e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—epilepsy syndrome	1.65e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—epilepsy syndrome	1.61e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—epilepsy syndrome	1.58e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—epilepsy syndrome	1.54e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—epilepsy syndrome	1.44e-06	9.68e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	1.13e-06	7.62e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—epilepsy syndrome	1.13e-06	7.6e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.05e-06	7.06e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	6.89e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.01e-06	6.78e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—epilepsy syndrome	9.54e-07	6.43e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—epilepsy syndrome	7.99e-07	5.38e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	7.51e-07	5.06e-06	CbGpPWpGaD
